ClinicalTrials.gg
Not yet recruitingNCT07745959Updated Aug 4, 2026

Effect of Virtual Reality Before Upper Gastrointestinal Endoscopy on Preprocedural Anxiety, Psychological Readiness, and Postprocedural Satisfaction

An interventional study of Virtual Reality and Standard Preprocedural Care in Upper Gastrointestinal Disorders, sponsored by Ardahan University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-04.

Sponsored by Ardahan University · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
52
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 11 studies in Gastrointestinal Diseases with a site in Turkey — 3 open to participants now, 4 under way, none of them phase 3. Gastrointestinal Diseases · Turkey.

Started
2026
with 1 other
No phase
6 of 11
2 open now
Registered
11th of 11
by date
Lead sponsor
1 of 11
Ardahan University

Among the 11 studies in Gastrointestinal Diseases with a site in Turkey, this one is one of 2 that started in 2026, is one of 6 with no phase, and was the 11th registered.

Gastrointestinal Diseases

549 studies on the registry are indexed under Gastrointestinal Diseases; 102 are open to participants now.

Browse Gastrointestinal Diseases studies →

Open to participants now

3 of the 11 studies in Gastrointestinal Diseases with a site in Turkey are open now. Recruiting first, the newest first:

All 3 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 66 Gastrointestinal Diseases studies recruiting now, 30 (45%) set no upper age limit and 23 (35%) stop at 75 or younger; 19 take children under 18; 21 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 11 studies in Gastrointestinal Diseases with a site in Turkey, or all of them as a file.
02

Study summary

Objective: This study aims to evaluate the effect of virtual reality applied before upper gastrointestinal endoscopy on preprocedural anxiety, psychological readiness, and postprocedural satisfaction.

Methods: This randomized controlled trial will be conducted in the Endoscopy Unit of Kelkit State Hospital. A total of 64 patients scheduled to undergo upper gastrointestinal endoscopy will be enrolled and randomly assigned in a 1:1 ratio to either the virtual reality intervention group or the control group. Participants in the intervention group will receive a virtual reality application before the endoscopy procedure, whereas participants in the control group will receive standard care. Data will be collected using the Endoscopy Patient Information Form, the State Anxiety Inventory (STAI-I), a single-item Psychological Readiness Assessment, and a single-item Postprocedural Satisfaction Assessment. Anxiety and psychological readiness will be evaluated before the procedure, and patient satisfaction will be assessed immediately after the procedure.

Expected Results: It is anticipated that the virtual reality intervention will reduce preprocedural anxiety, improve psychological readiness, and increase postprocedural satisfaction compared with standard care.

Read the detailed description

Upper gastrointestinal endoscopy is one of the most frequently performed diagnostic procedures for evaluating disorders of the upper gastrointestinal tract. Although it is generally considered safe, many patients experience considerable anxiety before the procedure. High levels of preprocedural anxiety may negatively affect psychological readiness, reduce patient cooperation, impair the overall procedural experience, and decrease satisfaction with care. Therefore, effective non-pharmacological interventions that improve the patient's psychological state before endoscopy are needed.

Virtual reality (VR) is an immersive technology that provides visual and auditory stimulation, allowing individuals to become engaged in a relaxing virtual environment and divert their attention from stressful situations. Previous studies have demonstrated that virtual reality can reduce anxiety, pain, and physiological stress during various medical procedures. However, evidence regarding the effectiveness of virtual reality when applied before upper gastrointestinal endoscopy, particularly its effects on psychological readiness and postprocedural satisfaction, remains limited.

This randomized controlled trial aims to evaluate the effect of virtual reality applied before upper gastrointestinal endoscopy on preprocedural anxiety, psychological readiness, and postprocedural satisfaction. The study will be conducted in the Endoscopy Unit of Kelkit State Hospital. A total of 64 patients who meet the eligibility criteria will be randomly assigned in a 1:1 ratio to either the virtual reality intervention group or the control group using block randomization.

Participants in the intervention group will receive a virtual reality application before the endoscopy procedure in addition to standard care. Participants in the control group will receive standard preprocedural care only. Data will be collected using the Endoscopy Patient Information Form, the State Anxiety Inventory (STAI-I), a single-item Psychological Readiness Assessment, and a single-item Postprocedural Satisfaction Assessment. Anxiety and psychological readiness will be evaluated before the procedure, while postprocedural satisfaction will be assessed immediately after completion of the endoscopy.

The findings of this study are expected to provide evidence regarding the effectiveness of virtual reality as a simple, non-invasive, and low-cost intervention for reducing preprocedural anxiety, improving patients' psychological readiness for upper gastrointestinal endoscopy, and enhancing satisfaction with the procedure. The results may contribute to the development of evidence-based nursing interventions and improve patient-centered care in endoscopy units.

03

Conditions studied

  • Upper Gastrointestinal Disorders

Keywords

  • Virtual Reality
  • Upper Gastrointestinal Endoscopy
  • Preprocedural Anxiety
  • Psychological Readiness
  • Patient Satisfaction
  • State Anxiety
  • Endoscopy
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 18 years or older
  • Scheduled to undergo upper gastrointestinal endoscopy
  • Able to understand and communicate in Turkish
  • Willing to participate in the study
  • Providing written

Exclusion criteria

Exclusion Criteria:

  • Presence of a diagnosed psychiatric or neurological disorder that may interfere with participation
  • Presence of a visual, hearing, head, face, or eye condition that prevents the use of a virtual reality headset
  • History of severe vertigo, motion sickness, or balance disorder
  • Development of severe dizziness, nausea, eye strain, or discomfort during the virtual reality intervention
  • Refusal to participate or withdrawal from the study
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
52 participants (estimated)

Study arms

  • Experimental
    Experimental

    Participants will receive a virtual reality intervention before upper gastrointestinal endoscopy in addition to standard preprocedural care. The virtual reality application will be administered before the endoscopy procedure using a virtual reality headset.

    Device: Virtual Reality

  • Active comparator
    Standard Care Group

    Participants will receive a virtual reality intervention using a virtual reality headset before upper gastrointestinal endoscopy. The intervention is designed to reduce preprocedural anxiety, improve psychological readiness, and enhance patient satisfaction.

    Other: Standard Preprocedural Care

Interventions

  • DeviceVirtual Reality

    Participants will receive the institution's standard preprocedural care before upper gastrointestinal endoscopy without the virtual reality intervention.

  • OtherStandard Preprocedural Care

    Participants will receive the institution's routine preprocedural care before upper gastrointestinal endoscopy without virtual reality.

06

What researchers measure

Primary outcomes

  1. Preprocedural Anxiety

    Preprocedural anxiety will be assessed using the State Anxiety Inventory (STAI-I). The STAI-I consists of 20 items scored on a 4-point Likert scale. Total scores range from 20 to 80, with higher scores indicating higher levels of state anxiety.

    Time frame: Immediately before upper gastrointestinal endoscopy

Secondary outcomes

  1. Psychological Readiness

    Psychological readiness will be assessed using a single-item question asking participants how psychologically prepared they feel for the endoscopy procedure. Responses are scored from 1 (not at all prepared) to 5 (very well prepared), with higher scores indicating greater psychological readiness.

    Time frame: Immediately before upper gastrointestinal endoscopy

  2. Postprocedural Satisfaction

    Postprocedural satisfaction will be assessed using a single-item satisfaction question scored from 1 (not satisfied at all) to 5 (very satisfied). Higher scores indicate greater patient satisfaction with the endoscopy procedure.

    Time frame: Immediately after upper gastrointestinal endoscopy

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Aug 2026; primary completion for Feb 2027, 5 months later.

Of 127 non-industry interventional studies with no phase under Gastrointestinal Diseases, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 46. This study's planned 5 months is below that.

Counting every sponsor, half of 149 studies reached it within 24 months; a quarter within 10 and three quarters within 45.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 30, 2026
First posted
Aug 4, 2026
StartEst.
Aug 30, 2026
Primary completionEst.
Feb 28, 2027
CompletionEst.
Mar 31, 2027
Last update
Aug 4, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 4, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07745959
Lead sponsor
Ardahan University
Collaborators
Gümüşhane Universıty
Responsible party
Derya Şimşekli (Assistant Professor, Ardahan University) — Principal investigator
First posted
Aug 4, 2026
Start date
Aug 30, 2026 (estimated)
Primary completion
Feb 28, 2027 (estimated)
Completion
Mar 31, 2027 (estimated)
Last update
Aug 4, 2026

Study contacts

DERYA ŞİMŞEKLİ, PhD
Contact
deryasimsekli@ardahan.edu.tr
+905545965789
DERYA ŞİMŞEKLİ, Dr.
principal investigator · Ardahan University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion